Advertisement
Advertisement
U.S. markets open in 8 hours 18 minutes
Advertisement
Advertisement
Advertisement
Advertisement

TRxADE HEALTH, Inc. (MEDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.6000-0.0200 (-1.23%)
At close: 02:46PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close1.6200
Open1.5701
Bid0.0000 x 1000
Ask0.0000 x 900
Day's Range1.4932 - 1.6900
52 Week Range1.1600 - 9.4900
Volume8,240
Avg. Volume74,643
Market Cap13.09M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-0.6890
Earnings DateJul 25, 2022 - Jul 29, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.08
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MEDS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • TRxADE HEALTH, Inc.
    Weekly Stock ListStocks have struggled in 2Q 2022, with the S&P 500 on its way to a double-digit drop for the period. Absent the rally in recent days, the decline would be closer to 20%. Growth stocks have again been the weakest performers, as sectors such as Technology, Communication Services, and Consumer Discretionary all have lagged the major market indices. The leading sectors were value-oriented, including Energy, Consumer Staples, Basic Materials, and Utilities. The average stock in the Argus Universe of Coverage has declined 13.1% thus far during the quarter, and the median stock declined 12.5%. The average BUY-rated stock dropped 12.6%, while the average HOLD-rated stock fell 14.4%. Will investors continue to favor value in 2022? Will high inflation drive continued outperformance in Energy and Basic Materials? Given interest rates that remain historically low, we expect growth stocks to resume outperformance over time, and think 2022 may be a "one-in-five year" that value leads. Investors seeking value are encouraged to focus on dividends and look for yields in the 3%-4% range. Concerning sectors, our current Over-Weights are Energy, Financial, Healthcare, Industrials, and Basic Materials. Here are the top-10 and bottom-five performers from the Argus Universe in 2Q.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
Advertisement
Advertisement